DGX vs IMNM · P/E 22, rev $5.94B vs $2.47B cap
Quest Diagnostics Incorporated (DGX) versus Immunome Inc (IMNM) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Immunome Inc (IMNM) is a biotechnology company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported IMNM revenue for 2026-06-30 was $0. Net income was -$127.0M. IMNM currently screens at market cap $2.47B.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. IMNM currently screens at market cap $2.47B.
Not investment advice. Open the DGX and IMNM stock pages for the full models.
Not investment advice.